glaxosmithkline_pfizer_95819.jpg - Washington Times
Skip to content

FILE - This April 20, 2009 file photo, shows the British pharmaceuticals firm GlaxoSmithKline in London. Drugmakers GlaxoSmithKline and Pfizer are merging their healthcare divisions, creating a business with combined sales of 9.8 billion pounds ($12.7 billion). British-based Glaxo will own 68 percent of the joint venture, while U.S.-based Pfizer will own the remaining 32 percent stake. (AP Photo/Sang Tan, File)

FILE - This April 20, 2009 file photo, shows the British pharmaceuticals firm GlaxoSmithKline in London. Drugmakers GlaxoSmithKline and Pfizer are merging their healthcare divisions, creating a business with combined sales of 9.8 billion pounds ($12.7 billion). British-based Glaxo will own 68 percent of the joint venture, while U.S.-based Pfizer will own the remaining 32 percent stake. (AP Photo/Sang Tan, File)

Featured Photo Galleries